Papers
5
Total Citations
15
H-Index
2
About
Ting-Wen Sheng is a rising researcher in urologic oncology, whose work centers on the interplay between body composition, adipose tissue biology, and surgical outcomes in prostate and kidney cancers. Her major contributions include demonstrating that pelvic fat distribution and body composition are not merely passive bystanders but active predictors of prostate cancer aggressiveness and biochemical recurrence—a finding with 7 citations that offers a novel, non-invasive prognostic tool. In a groundbreaking 2024 study, she revealed that periprostatic adipose tissue can paradoxically inhibit tumor progression by secreting apoptotic factors, suggesting a natural immune-mediated barrier during early-stage disease. Sheng has also advanced clinical practice by developing a simplified nomogram integrating clinical and imaging parameters to predict early post-prostatectomy incontinence recovery, and by creating risk assessment models for bleeding complications in robotic-assisted partial nephrectomy for renal angiomyolipoma. Her work, accumulating over 15 citations, bridges metabolic health and surgical precision, offering practical tools for personalized patient counseling and highlighting the dual role of fat in cancer biology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5